What are the bedside decision‑making considerations for enteral and parenteral nutrition, including feeding during vasopressor therapy, choice of gastric versus post‑pyloric feeding, and indications for supplemental parenteral nutrition?

Enteral and Parenteral Nutrition: Bedside Decision-Making

Feeding During Vasopressor Therapy

Initiate enteral nutrition in adequately resuscitated patients on low-dose vasopressors (norepinephrine < 0.3 μg/kg/min with normalized lactate), but avoid high-dose feeding until vasopressors are weaned below this threshold 1.

The critical distinction is between resuscitation status and vasopressor dose:

• Safe to start EN: Patients on norepinephrine < 0.3 μg/kg/min who are adequately resuscitated (normalized lactate) 1
• Delay or use low-dose feeding: Patients on norepinephrine ≥ 0.3 μg/kg/min should receive conservative nutrition (6 kcal/kg/day, 0.2-0.4 g/kg/day protein) until vasopressors are weaned 1
• Absolute contraindications: Unresuscitated hemodynamic instability, intestinal ischemia, abdominal compartment syndrome 1

The Nutrirea-3 trial demonstrated that full-dose nutrition (25 kcal/kg/day) versus low-dose (6 kcal/kg/day) in patients on vasopressors (mean norepinephrine 0.5 μg/kg/min) increased ICU length of stay by one day without mortality benefit 1. This reinforces that clinical signs of adequate resuscitation (lactate clearance, capillary refill, urine output) matter more than arbitrary vasopressor cutoffs 2.

Practical Algorithm for Vasopressor Patients:

1. Assess resuscitation status: lactate trending down, adequate perfusion markers
2. Check norepinephrine dose
3. If < 0.3 μg/kg/min + resuscitated → initiate EN at 10-15 kcal/kg
4. If ≥ 0.3 μg/kg/min → wait for weaning OR use conservative feeding (< 70% targets)
5. Monitor for feeding intolerance: abdominal distension, rising lactate, decreased bowel sounds

Common pitfall: Starting aggressive feeding too early in shock increases risk of non-occlusive mesenteric ischemia. The key is patience during the acute phase 1, 3.

---

Gastric vs Post-Pyloric Feeding

Start with gastric feeding as the standard approach; escalate to post-pyloric (jejunal) feeding only when gastric intolerance persists despite prokinetics or when aspiration risk is high 4.

Decision Algorithm:

First-line: Gastric feeding 4

• Easier placement, faster initiation
• Physiologically more normal
• Use continuous rather than bolus administration to reduce diarrhea (RR 0.42) 4

Escalation pathway when gastric feeding fails:

1. Implement prokinetic therapy first 4, 3:

   • Intravenous erythromycin 100-250 mg three times daily (first-line, Grade B) 4
   • Alternative: IV metoclopramide 10 mg 2-3 times daily
   • Combination therapy if single agent fails
   • Duration: 2-4 days

2. Switch to post-pyloric feeding if:

   • Persistent feeding intolerance despite prokinetics 4
   • High aspiration risk (severe GERD, recurrent aspiration, depressed mental status) 4, 3
   • Severe gastroparesis

Evidence Nuances:

Meta-analysis shows post-pyloric feeding reduces feeding intolerance (RR 0.16) and trends toward less pneumonia (RR 0.75, p=0.07), but shows no mortality difference 4. This means post-pyloric feeding is a tolerance strategy, not a survival strategy.

Feeding intolerance should be interpreted as: large gastric residuals (though thresholds are controversial), abdominal distension, vomiting, or inability to advance feeds 5. Don't reflexively switch to post-pyloric for single episodes of high residuals—use prokinetics first 4.

---

Supplemental Parenteral Nutrition (SPN)

Initiate supplemental parenteral nutrition when enteral nutrition cannot meet 60-70% of energy/protein targets after 7-10 days in high nutrition-risk patients, or earlier if enteral nutrition is contraindicated 6, 5.

Indications for Parenteral Nutrition:

Absolute indications (start TPN immediately) 3, 6:

• Intestinal obstruction
• Severe ileus unresponsive to management
• High-output enterocutaneous fistula
• Intestinal ischemia
• Non-functional GI tract

Relative indications (consider SPN) 6, 5:

• Persistent EN intolerance after post-pyloric feeding trial
• Cannot achieve > 60% of energy/protein targets via EN by day 7-10
• High nutrition risk (modified NUTRIC score ≥ 5) with inadequate EN 3
• Post-ICU phase with persistent energy/protein deficits and poor oral intake 6

Timing and Dosing Strategy:

Early acute phase (days 1-3): Avoid PN unless EN absolutely contraindicated. Start EN at 10-15 kcal/kg or < 70% of measured energy expenditure 1, 5.

Stabilization phase (days 4-10):

• Assess EN adequacy
• If consistently < 60% targets despite optimization → consider SPN 6
• Target combined EN + PN to reach 70-80% of indirect calorimetry-measured energy expenditure 1

Late ICU/post-ICU recovery: SPN plays a larger role as energy and protein deficits accumulate, particularly when oral intake remains poor and rehabilitation is ongoing 6, 5.

Critical Safety Points:

• Avoid overfeeding: Historical PN complications were driven by excessive calories, not the route itself 6
• Strict aseptic technique: Modern PN with conservative dosing is as safe as EN when infection control is rigorous 6
• Monitor refeeding syndrome: Check phosphate, potassium, magnesium before and during PN initiation, especially if phosphate < 0.65 mmol/L 1
• Peripheral PN (PPN) can bridge short-term gaps (< 7 days) when central access is unavailable 6

Common Pitfall:

Delaying PN indefinitely in patients with prolonged inadequate EN leads to cumulative energy/protein deficits that impair recovery and muscle preservation 6, 5. Don't let "EN-first" dogma prevent appropriate PN use in patients who genuinely cannot tolerate adequate enteral feeding.

---

Overarching Principles for Bedside Decision-Making

Phase-Based Nutrition Strategy 1, 5:

Early acute phase (days 1-3):

• Conservative energy: 10-15 kcal/kg or < 70% of IC-measured REE
• Prioritize tolerance over targets
• Avoid high-dose feeding on vasopressors ≥ 0.3 μg/kg/min

Stabilization phase (days 4-10):

• Advance to 70-80% of IC-measured targets
• Address persistent feeding intolerance with prokinetics → post-pyloric → SPN
• Use indirect calorimetry if available (most accurate, avoids predictive equation errors) 1, 4

Late ICU/post-ICU recovery:

• Target full energy/protein needs
• Combine nutrition with rehabilitation and resistance exercise 1
• Consider SPN if oral intake inadequate 6

Personalization Markers 1, 5:

• Nutrition risk: Modified NUTRIC or NRS-2002 scores
• Metabolic measurement: Indirect calorimetry (respiratory quotient < 0.7 = underfeeding, > 1.0 = overfeeding)
• Resuscitation status: Lactate, perfusion markers
• GI function: Tolerance, bowel sounds, residuals
• Functional trajectory: Muscle mass, strength, rehabilitation participation

The key to bedside decision-making is recognizing that nutrition is not static—it must adapt to the patient's metabolic phase, organ function, and recovery trajectory 5.